Insider Transactions by Van Naarden Jacob

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
LLYELI LILLY & CoVan Naarden JacobEVP & Pres., Loxo@LillyFeb 12, 2024Option Exercise$737.262,3691,746,56916,147Feb 14, 2024, 04:41 PM
LLYELI LILLY & CoVan Naarden JacobEVP & Pres., Loxo@LillyFeb 01, 2024Option Exercise$645.611,6851,087,85313,778Feb 02, 2024, 04:22 PM
LLYELI LILLY & CoVan Naarden JacobEVP and CEO Loxo@LillyFeb 16, 2023Option Exercise$335.011,314440,20311,845Feb 21, 2023, 04:35 PM
LLYELI LILLY & CoVan Naarden JacobEVP and CEO Loxo@LillyFeb 10, 2023Option Exercise$345.122,407830,70410,374Feb 14, 2023, 05:07 PM
LLYELI LILLY & CoVan Naarden JacobSVP, CEO LoxoONC, Pres LlyONCFeb 16, 2022Option Exercise$243.842,186533,0347,967Feb 17, 2022, 04:44 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Operating OfficerFeb 15, 2019Option Exercise$235.0019,0004,465,0000Feb 15, 2019, 09:18 AM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Operating OfficerJul 09, 2018Option Exercise$3.651,5415,62213,541Jan 17, 2019, 08:08 AM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 11, 2018Sale$44.0716,000705,13120,700Dec 12, 2018, 05:17 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 10, 2018Sale$73.669,000662,94918,200Dec 12, 2018, 05:17 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 26, 2018Sale$78.3911,000862,28819,200Nov 28, 2018, 05:13 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 27, 2018Sale$74.959,000674,51218,200Nov 28, 2018, 05:13 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 03, 2018Sale$85.4011,000939,44019,200Oct 05, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 04, 2018Option Exercise$83.149,000748,30018,200Oct 05, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 13, 2018Sale$84.819,000763,31918,200Sep 14, 2018, 06:14 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 12, 2018Sale$85.1211,000936,34119,200Sep 14, 2018, 06:14 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 13, 2018Sale$81.2611,000893,86819,200Aug 15, 2018, 05:27 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 14, 2018Sale$81.789,000736,05818,200Aug 15, 2018, 05:27 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJul 09, 2018Sale$95.473,082294,25315,241Jul 11, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJul 10, 2018Option Exercise$91.673,082282,52815,241Jul 11, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJun 19, 2018Sale$90.293,082278,2871,541Jun 21, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJun 20, 2018Sale$21.6015,082325,76813,541Jun 21, 2018, 05:03 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMay 14, 2018Sale$70.593,082217,5711,541May 16, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMay 15, 2018Sale$70.473,082217,1881,541May 16, 2018, 04:46 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerApr 25, 2018Sale$67.223,082207,1841,541Apr 26, 2018, 04:32 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerApr 24, 2018Option Exercise$67.663,082208,5201,541Apr 26, 2018, 04:32 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMar 13, 2018Sale$67.503,082208,0361,541Mar 15, 2018, 05:01 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerMar 14, 2018Sale$67.553,082208,2021,541Mar 15, 2018, 05:01 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerFeb 12, 2018Sale$48.543,082149,5991,541Feb 14, 2018, 05:35 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerFeb 13, 2018Sale$51.453,082158,5561,541Feb 14, 2018, 05:35 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJan 17, 2018Sale$45.973,082141,6861,541Jan 18, 2018, 05:02 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerJan 16, 2018Sale$45.893,082141,4231,541Jan 18, 2018, 05:02 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 14, 2017Sale$43.463,082133,9401,541Dec 18, 2017, 05:42 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerDec 15, 2017Option Exercise$41.383,082127,5431,541Dec 18, 2017, 05:42 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 27, 2017Sale$39.243,082120,9381,541Nov 29, 2017, 05:21 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerNov 28, 2017Sale$38.903,082119,9031,541Nov 29, 2017, 05:21 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 30, 2017Sale$45.453,082140,0891,541Nov 01, 2017, 05:06 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerOct 31, 2017Sale$45.083,082138,9431,541Nov 01, 2017, 05:06 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 18, 2017Sale$46.433,082143,0831,541Sep 20, 2017, 05:05 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerSep 19, 2017Sale$46.223,082142,4491,541Sep 20, 2017, 05:05 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 15, 2017Sale$38.533,082118,7551,541Aug 16, 2017, 05:22 PM
LOXOLoxo Oncology, Inc.Van Naarden JacobChief Business OfficerAug 14, 2017Sale$38.693,082119,2411,541Aug 16, 2017, 05:22 PM